Hepatic FNDC5 is a potential local protective factor against Non-Alcoholic Fatty Liver-Reference-Cited by-同舟云学术

Hepatic FNDC5 is a potential local protective factor against Non-Alcoholic Fatty Liver

Published:2020-05 Issue:5 Volume:1866 Page:165705
ISSN:0925-4439
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Author:

Canivet Clémence M.,Bonnafous Stéphanie,Rousseau Déborah,Leclere Pierre S.,Lacas-Gervais Sandra,Patouraux Stéphanie,Sans Arnaud,Luci Carmelo,Bailly-Maitre Béatrice,Iannelli Antonio,Tran Albert,Anty Rodolphe,Gual Philippe

Funder

Institut National de la Santé et de la Recherche Médicale

Société Francophone du Diabète

Agence Nationale de la Recherche

Publisher

Elsevier BV

Subject

Molecular Biology,Molecular Medicine

Reference57 articles.

1. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016

2. Triglyceride accumulation protects against fatty acid-induced lipotoxicity;Listenberger;Proc. Natl. Acad. Sci. U. S. A.,2003

3. Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases;Samuel;Cell Metab.,2018

4. Diabetes mellitus predicts occurrence of cirrhosis and hepatocellular cancer in alcoholic liver and non-alcoholic fatty liver diseases;Raff;J. Clin. Transl. Hepatol.,2015

5. Non-alcoholic fatty liver disease and risk of type 2 diabetes;Lallukka;Best Pract. Res. Clin. Endocrinol. Metab.,2016

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The time course of irisin release after an acute exercise: relevant implications for health and future experimental designs;European Journal of Translational Myology;2024-07-01

2. Genetic predisposition to metabolic dysfunction-associated fatty liver disease;CHILD`S HEALTH;2024-05-26

3. Musculoskeletal health in children and adolescents;Frontiers in Pediatrics;2023-12-15

4. Potential role of irisin in digestive system diseases;Biomedicine & Pharmacotherapy;2023-10

5. Circulating irisin in nonalcoholic fatty liver disease: an updated meta-analysis;Endokrynologia Polska;2023-02-27